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Abstract
Compelling evidence suggests that the early interaction between porcine circovirus 2 (PCV-2) and the innate immune
system is the key event in the pathogenesis of Post-Weaning Multisystemic Wasting Syndrome (PMWS). Furthermore, PCV2
has been detected in bone-marrow samples, potentially enabling an easy spread and reservoir for the virus. To assess the
gene-expression differences induced by an in-vitro PCV2b infection in different three different myeloid innate immune cell
subsets generated from the same animal, we used the Agilent Porcine Gene Expression Microarray (V2). Alveolar
macrophages (AMØs), monocyte-derived dendritic cells (MoDCs) and bone-marrow cells (BMCs) were generated from each
animal, and challenged with a UK-isolate of a PCV2 genotype b-strain at a MOI of 0.5. Remarkably, analysis showed a highly
distinct and cell-type dependent response to PCV2b challenge. Overall, MoDCs showed the most marked response to
PCV2b challenge in vitro and revealed a key role for TNF in the interaction with PCV2b, whereas only few genes were
affected in BMCs and AMØs. These observations were further supported by an enrichment of genes in the downstream NF-
kB Signalling pathway as well as an up regulation of genes with pro-apoptotic functions post-challenge. PCV2b challenge
increases the expression of a large number of immune-related and pro-apoptotic genes mainly in MoDC, which possibly
explain the increased inflammation, granulomatous inflammation and lymphocyte depletion seen in PMWS-affected pigs.
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Introduction
PCV2, a non-enveloped, single-stranded circular DNA virus,
has been recognized as the underlying agent for Post Weaning
Multisystemic Wasting Syndrome (PMWS) [1,2] and is now
endemic in most pig-producing countries. Thus far, three
genotypes of PCV2 have been described. PCV2a first reported
in archived tissue samples, PCV2b, first reported in 2005 in North
America and PCV2c recently described in Denmark [3–5].
Previous studies did not show differences in virulence of different
PCV2 strains [1,6]; however recent evidence suggests that
mutations in circulating PCV2 strains coincided with a dramatic
change of pathogenicity and clinical outcome [3,7], with pigs
carrying numerous PCV2 genotypes [8]. The fact that PCV2 has
been detected in both PMWS and non-PMWS affected farms and
pigs contributed to the notion that different PCV2 strains vary in
their pathogenicity [9]. In that context it has to be noted that the
dominant PCV2 strain circulating on severely-affected farms in the
UK was grouped into genotype PCV2b, as determined in a recent
cross-sectional study involving 147 pig farms across England [10].
Whereas the majority of endemic diseases can be controlled by
vaccination or eradication of the pathogen, these approaches are
less successful in the control of multi-factorial diseases. PMWS
represents a typical multi-factorial disease, with pigs between 5
and 12 weeks of age being affected, and which is characterized by
increased mortality, weight loss, wasting, dyspnoea and enlarged
lymph nodes [8,11,12]. Indeed, vaccination against PCV2 seems
to be successful in that it is reducing losses on affected farms, but is
not inducing sterile immunity and vaccinated pigs still seem to
harbour and potentially shed PCV2 [13,14]. In this respect, the
infected cells are of great importance for the distribution of PCV2.
Viruses have evolved complex immune evasion strategies for
protection against host immune responses [15], and PCV2-
infected pigs seem to harbour the virus in different immune cell
subsets [13,14] without infected cells showing signs of functional
differences. Particularly alveolar macrophages (AMØs) and other
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cell-types of the monocyte/macrophage lineage seem to act as
reservoirs and Trojan horse for PCV2, subsequently infecting
other immune cells and specifically bone-marrow cells [14,16].
Lymphocyte depletion, secondary infections with opportunistic
pathogens, induction of apoptosis and other changes in immune
cell subpopulations and PBMCs are all common characteristics of
PMWS in severely affected pigs, strongly suggesting an immuno-
suppressive status [13,17,18]. Indeed, PCV2b-infected plasmacy-
toid dendritic cells (pDC) were shown to be unresponsive to
exposure to further ‘‘danger-signals’’ [19,20], supporting the
notion that PCV2 induces a status of immunsuppression.
However, the mechanism by which the immune system is altered
remains unclear. A proposed mechanism suggests the presence of
immunomodulatory CpG motif in the small circular genome of
PCV2 inhibiting critical cytokine secretion [21,22].
In the last decade, gene expression profiling microarrays have
been widely used to reveal the effects of pathogens on host cells
and tissues aiming to gain insight into the molecular mechanisms
involved in the host-pathogen interactions [23,24], and a limited
number of studies have been performed applying the benefits of
microarrays to elucidate the pathogenesis of PCV infection [24–
27]. In all of these studies, tissues from PCV-infected pigs, rather
than specific cellular subsets were analysed. Whereas this allows
for a discrimination of genes being differentially expressed in
different tissues as a result of the infection, it does not allow for the
discrimination of PCV-induced effects in specific cell-types. These
ex vivo data showed differential expression of numerous genes in
PCV2-infected animals involved in innate immune defence
(TLR1, CD14 and CD180), immunosuppressive responses
(FGL2 and GPNMB) and pro-inflammatory signals (galectin-3)
[24].
Due to the difficulty of reproducing an experimental model of
PMWS and lack of advanced pig molecular markers [28], the
objective of the present study was to analyse the early molecular
mechanisms involved in PCV2b infection of three defined immune
cell subsets generated from the same animals, using a genome-
wide expression approach. Information obtained from this study
will increase our understanding of the features of PCV2 infection
during the onset of immune responses in vivo.
Materials and Methods
Ethics Statement
All animal studies were performed according to the regulations
and guidance provided under the UK Home Office Animals
(Scientific Procedures) Act 1986. Experimental protocols were
approved under project licence number PPL 70/7219, as well as
the RVC Ethics and Welfare Committee.
Animals
Six crossbred Large White6Landrace pigs (Sus scrofa), free of
PCV1, PCV2, swine influenza strains H1N1, H1N3, and H1N5,
PRRSV and Mycoplasma hyopneumoniae, as confirmed by qPCR and
antibody testing, were sourced from the Animal Health and
Veterinary Laboratories Agency (AHVLA) and housed at the pig
unit of the Royal Veterinary College. At 6 months of age, all six
pigs were humanly euthanized. During housing, PCV2 status of
the pigs was repeatedly confirmed by ELISA (antibody) and
quantitative real-time PCR on serum. All six pigs remained PCV2
negative throughout.
Generation of immune cell subsets
From each individual animal, the following immune cell subsets
were generated:
Porcine alveolar macrophages (AMØs). Porcine AMØs
were obtained from the lungs of each euthanized PCV2-negative
pig (n = 6). Briefly, approximately 26500 ml of sterile PBS
(containing 200 mg ml21 gentamycin and 2.5 mg ml21 amphoter-
icin B) were delivered into the freshly isolated lungs via tracheal
intubation. Following gentle manipulation to detach loosely
adherent cells, the aspirate was removed and the resulting cell
suspension was placed in a sterile 500 ml bottle. AMØ were
recovered following centrifugation (2006 g for 10 min at 4uC),
washed once and resuspended in growth medium (RPMI 1640
supplemented with 10% (v/v) porcine serum, 200 mg ml21 Pen/
Strep and 0.5 mg ml21 amphotericin B). AMØs were seeded at
16106 cells ml21 and incubated at 37uC/5% CO2 in 6-well plates
(Nalgene, USA). The majority of isolated cells expressed the
surface antigens CD14 and MHC class II, as analysed by flow-
cytometry (data not shown).
Generation of monocyte-derived dendritic cells
(MoDCs). Just before euthanasia, 500 ml of blood was collected
from each pig ( = 6) into sterile bottles, containing acid citrate
dextrose solution (0.22 M D(+)glucose, 0.2 M sodium citrate and
0.14 M citric acid) at 10% of the total volume. The blood was
divided into 50 mL falcon tubes and centrifuged at 10006 g for
25 min. The buffy coat was removed and collected in a sterile glass
bottle, diluted 1:2 (v/v) with calcium/magnesium free PBS (PBSa)
at room temperature. Peripheral blood mononuclear cells
(PBMCs) were isolated from the buffy coat via density centrifu-
gation over Histopaque (Histopaque 1.077 g ml21, Sigma, Poole,
Dorset, UK) as described previously [29]. After centrifugation
(8006 g for 25 min at 22uC), the mononuclear cells were
recovered from the interface formed between the cell suspension
and the Histopaque and washed twice by dilution in cold (4uC)
PBS-A 0.03% (w/v) EDTA (PBS/EDTA) and centrifugation
(3506 g/10 min/4uC). CD14+ monocytes were isolated by
positive selection using a MACS system (Miltenyi Biotech,
Bergisch Gladbach, Germany), according to the manufacturer’s
protocol. The cells were cultured for 7 days in DMEM medium
with porcine serum (10% v/v), recombinant porcine (rp)
granulocyte–macrophage colony-stimulating factor (GM-CSF,
150 ng ml21) and rp interleukin-4 (IL-4, 100 U ml21). RpIL-4
and rpGM-CSF were prepared in house, and bioactivity of both
cytokines was determined using a TF-1 cell bioassay, with the IL-4
concentration giving half-maximum proliferation being defined as
1 unit. Resulting cells were CD14low, and expressed the DC-SIGN
molecule, consistent with the phenotype reported by Huang et al.,
2009 [30].
Generation of bone marrow cells (BMCs). BMCs were
isolated from the sternum of each pig (n = 6) as previously
described [31]. Briefly, the sternum was opened and flushed with
PBS/0?03% EDTA (w/v) at 37uC. The obtained cell suspension
was depleted of erythrocytes and mature granulocytes by
centrifugation over Histopaque (1.077 g ml21, Sigma, Poole,
Dorset, UK) at 10006 g for 40 min at room temperature. After a
further two PBS/EDTA washes (2506 g/10 min/4uC), the cells
were cultured for 7 days in aMEM medium with porcine serum
(10% v/v), 200 mg ml21 Pen/Strep, and 0.5 mg ml21 amphoter-
icin B.
Virus preparation for infection. To avoid potential false-
positive results due to LPS contaminations of reagents/media, all
substances used were tested for their LPS content using the
Endosafe-PTS system (Charles River, Charleston, USA). Samples
with an endotoxin content below 0.01 EU ml21 were considered
as LPS-free.
A previously characterized PCV2b isolate from the UK
(GenBank accession number JX193799; [10]) was used to generate
PCV2b and Cell-Specific Immune Response
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the virus stock for the experimental infections. The virus was
propagated in type-I IFNKO PK15-ALR-NPro cells, free of PCV1
and PCV2. Cells were cultured in MEM containing Earle’s salts
supplemented with 10% (v/v) tetracycline-free foetal bovine serum
(FBS) (Clontech, Saint-Germain-en-Laye, France). To induce the
tetracycline-regulated expression of the IFN-KO, tetracycline was
added 2 h pre-inoculation. Cell monolayers were inoculated at
50% confluence. After 18 h incubation at 37uC, the inoculum was
removed and retained, and the monolayer treated with 300 mM
D-glucosamine in Hanks balanced salt solution (HBSS) for 30 min
at 37uC. After removal of the glucosamine and subsequent washes
with HBSS, cultures were overlaid with retained inoculum.
Cultures were overlaid with media 24 h post-inoculation. After a
further 3 days incubation media was removed and retained and
virus harvested from trypsinised cells by freeze-thawing. The cell
lysate was clarified by centrifugation at 1,0006g for 5 min at 4uC
and the supernatant added to the retained media. This virus
suspension was then concentrated approximately 10-fold using
dialysis tubing (Spectra/Por, Biotech Cellulose Ester membrane;
Spectrum Europe B.V.) in polyethylene glycol (PEG 12000 flake;
Whyte Chemicals Ltd.) at 4uC. Concentrated virus suspension was
subsequently dialysed in MEM overnight and aliquoted. PCV2
stocks were titrated on PK15-ALR-NPro cells as described
elsewhere [1]. The titre of the virus stock was determined as
106.05 TCID50 ml
21.
In line with the general accepted rules for work with viruses, and
similar as described by others [14,20,32], supernatant of type-I
IFNKO PK15-ALR-NPro cells was used as true mock-infection
control to counteract gene expression changes induced by the cell
culture supernatant of PK15-ALR-NPro cells rather than being a
true result of PCV2b infection.
All three cell types generated from each pig were exposed on the
same day to either PCV2b at an MOI of 0.5 or remained
uninfected in six-well-plates for 0 h, 1 h and 24 h at 37uC. At the
0 h time-point, cells were overlaid with PCV2b stock at an MOI of
0.5 and immediately washed and lysed; this served as a further
control for normal gene expression within the cells. At time-points
indicated, cells were lysed in 600 mL GTC buffer (4 M guanidine
thiocyanate, 25 mM sodium citrate, 0.5% (w/v) sodium N-
lauroylsarcosine, 0.1 M 2-mercaptoethanol, pH 7) after two
washes, as required for subsequent RNA extraction.
Assessment of infection by qPCR
The number of PCV2 copies per ng of cDNA isolated from
each cell type was determined by comparison to known standards
using qPCR. Each sample was measured in triplicate and in a final
volume of 20 ml per well in Microamp fast optical 48-microtiter
well plates (Applied Biosystems). Each well contained, 2 ml of
cDNA (standard or test sample), 10 ml of 26TaqMan Universal
Master Mix II (Applied Biosystems), 50 pmol of each primer
(Forward: 59-GCTCTYTATCGGAGGATTAC-39, Reverse: 59-
ATAAAAACCATTACGAWGTGATA-39) (MWG) and 2.5 mM
of TaqMan probe (59FAM-CCATGCCCTGAATTTCCATAT-
GAAAT-39TAMRA) (Applied Biosystems). The volume of each
well was adjusted to 20 ml by addition of nuclease-free water
(Sigma-Aldrich). The TaqMan probe and the primers were
designed to target a partial (137 bp) sequence of the ORF2 of
PCV2 [33]. Standard measurements were performed in a 10-fold
serial dilution from 109 PCV2 copies to 0 copies. After plate set up,
the qPCR was performed in a StepOne Real-time PCR machine
(Applied Biosystems) and StepOne software version 2.2.2 (Applied
Biosystems). The cycling conditions were 95uC for 10 mins for
polymerase activation followed by 40 cycles of denaturation at
95uC for 15 secs and annealing/extension at 55uC for 1 min. Data
was analysed using either StepOne software version 2.2.2 (Applied
Biosystems) or Excel 2010 (Microsoft). Ct values of triplicate
sample and standard measurements were averaged and this
average Ct value was used to calculate the PCV2 ORF2 copy
number in samples by comparison to the known standards. The
copy number in each sample was then divided by the nanograms
of DNA in that sample to give the PCV2 copy number per ng of
DNA.
Microarray hybridizations and data analysis. From all
cell types generated from each pig, total RNA was extracted at
each time point indicated from cells either mock- or PCV2-
infected, using the RNeasy kit (Qiagen, Crawley, UK) according
to the manufacturer’s instructions, including an RNase-free DNase
I (Qiagen, Crawley, UK) digestion step at the time-points
indicated. RNA integrity and quality was determined using the
Agilent 2100 Bioanalyzer (Agilent Technologies, Wokingham,
UK). Up to 50 ng of total RNA with RIN values $8 was reverse
transcribed to cDNA and then transcribed into Cy3-labelled
cRNA using the Low Input Quick Amp Gene Expression Labeling
Kit (Agilent, Santa Clara, CA) according to the manufacturer’s
instructions. Hybridization to the Agilent 4644K Porcine Gene
Expression Microarray (V2; Agilent) was performed on a Tecan
Hybridization Station HSPro400 (Tecan, Maennersdorf, Switzer-
land). Microarrays were scanned with an Agilent C Scanner
(Agilent Technologies, Wokingham, UK).
Figure 1. Quantitative PCR of PCV2b copy-numbers in immune
cell subsets. Cells were prepared and infected as described, and PCV2
copy numbers analysed at the time-points indicated (Fig. 1a). Effect of
PCV2 infection on immune cell subsets was also investigated by light
microscopical examination of infected cells (AMØs Fig. 1 c and d: MoDC
Fig. 1 f and g) compared to mock-infected cells (Fig. 1 b and e,
respectively). Magnification640.
doi:10.1371/journal.pone.0091081.g001
PCV2b and Cell-Specific Immune Response
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Following quality control checks and principal component
analysis (PCA), a subset of 12 arrays were removed. A total of 100
arrays were analysed with 38, 21 and 41 arrays representing
AMØs, BMCs and MoDCs respectively. Pre-processing steps of
background correction and between-array normalization were
performed prior to analysis using the software packages R (http://
www.r-project.org) and Bioconductor (http://www.bioconductor.
org) [34]. Differential expression analysis was performed by the
Bioconductor package limma using the functions lmFit and eBayes.
With increasing advancements in microarray technology, numer-
ous studies have now used a21.5# fold change (FC)$1.5 [35,36]
and have verified the biological significance of these transcripts
[37,38], consequently, in this study differences in gene expression
between the treatment groups were considered significant using
false discovery rate (FDR)-adjusted P,0.05 [40] and a
21.5#FC$1.5 as a cut-off.
Systems Biology Analysis. For further analysis, all differen-
tially expressed genes (P,0.05) were imported into the Ingenuity
Systems Pathway Analysis program (IPA; Ingenuity Systems,
Redwood City, CA, USA; http://www.ingenuity.com). Canonical
pathways analysis identified the pathways from the IPA library of
canonical pathways that were most significant to the data set.
Transcripts from the data set that met the 21.5#FC$1.5 and a
FDR-adjusted P,0.05 cut-off and were associated with a
canonical pathway in the Ingenuity Knowledge Base were
considered for the analysis. The significance of the association
between the data set and the canonical pathway is measured by
considering: (1) the number of focus genes that participate in that
process, (2) the total number of genes that are known to be
associated with that process in the selected reference set and lastly,
Fischer’s exact test is used to calculate a p-value and the corrected
p-value, using the Benjamini-Hochberg method [39], is displayed
for the Functions and Canonical Pathways (IPA).
Real time quantitative reverse transcription PCR (qRT-
PCR) analysis. The significance of differential expression
between PCV2b- challenged and unchallenged cells uncovered
by Agilent microarray analyses was further validated using real-
time PCR. cDNA was prepared from total RNA isolated from
each sample analysed in the microarray study using a High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems,
Figure 2. Differentially expressed genes in PCV2b-challenged and control immune cell subsets. Differentially expressed genes at each
time-point are shown for the two treatment comparisons (P,0.05, 21.5# fold change $1.5, N= 6).
doi:10.1371/journal.pone.0091081.g002
Figure 3. Transcriptome differences between immune cell
subsets challenged with PCV2b. Venn diagram of differentially
expressed genes after challenge with PCV2b is shown for each immune
cell subset (P,0.05, 21.5# fold change $1.5).
doi:10.1371/journal.pone.0091081.g003
PCV2b and Cell-Specific Immune Response
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Table 1. Annotated transcripts differentially expressed in AMØs, MoDCs and BMCs at 0 h, 1 h and 24 h p.i. following PCV2b
infection.
Cell type Time-point p.i. Gene symbol FC Gene description
AMØs 0 h PRDX6 2.58 Peroxiredoxin-6
1 h TNF 2.32 Tumor necrosis factor
MoDCs 1 h IL1B 6.47 Interleukin 1-beta
CXCL2 4.66 Chemokine (C-X-C motif) ligand 2
IL8 4.4 Interleukin 8
TNF 4.17 Tumor necrosis factor
IER3 3.4 immediate early response 3
CCL4 3.37 Chemokine (C-C motif) ligand 4
ADM 3.27 adrenomedullin
IL1A 3.2 Interleukin-1 alpha
MAP3K8 2.91 Mitogen-activated protein kinase 8
BTG2 2.35 B-cell translocation gene 2
RND3 2.29 rho Family GTPase 3
JAG1 2.15 jagged 1
TNFAIP3 2.14 tumor necrosis factor, alpha-induced protein 3
IRF1 2.1 interferon regulatory factor 1
NFKBIA 2.08 NF-kappa-B inhibitor alpha
IRG1 2.01 immune-responsive gene 1 protein homolog
MFSD2A 1.98 Major facilitator superfamily domain-containing protein 2
OSM 1.86 oncostatin M
HBEGF 1.84 heparin-binding EGF-like growth factor
CCL20 1.82 chemokine (C-C motif) ligand 20
STAB1 1.82 stabilin 1
TOB1 1.73 transducer of ERBB2, 1
SLC2A6 1.71 solute carrier family 2 (facilitated glucose transporter), member 6
CSRNP1 1.68 cysteine-serine-rich nuclear protein 1
MoDCs 24 h VDAC1P5 4.06 voltage-dependent anion channel 1 pseudogene 5
S100A9 3.3 S100 calcium binding protein A9
COX3 3.21 cytochrome oxidase 3
ARHGAP25 2.85 Rho GTPase activating protein 25
SLC25A6 2.71 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6
RPL32 2.46 ribosomal protein L32
MRPL18 2.28 mitochondrial ribosomal protein L18
RTN4 2.25 reticulon 4
TGH2 2.17 tissue transglutaminase homologue
PDLIM1 2.1 PDZ and LIM domain 1
PLCXD1 1.99 phosphatidylinositol-specific phospholipase C, X domain containing 1
CASP10 1.78 caspase 10, apoptosis-related cysteine peptidase
RANBP1 1.77 RAN binding protein 1
VDAC2 1.66 voltage-dependent anion channel 2
FCN1 21.75 ficolin (collagen/fibrinogen domain containing) 1
BTC 21.77 betacellulin
ITGB5 22.03 integrin, beta 5
PIK3IP1 22.05 phosphoinositide-3-kinase interacting protein 1
SEPP2 22.08 septin 2
RNASE4 22.27 ribonuclease, RNase A family, 4
DKK3 22.29 dickkopf 3 homolog
DUOXA2 23 dual oxidase maturation factor 2
PCV2b and Cell-Specific Immune Response
PLOS ONE | www.plosone.org 5 March 2014 | Volume 9 | Issue 3 | e91081
Life Technologies Corporation, Warrington, UK). cDNA conver-
sions were performed in 20 ml reaction volumes using random
primers as per manufacturer’s instructions.
Taqman gene expression assays (Applied Biosystems, Life
Technologies Corporation, Warrington, UK) were used to
determine expression of CXCL2, IL-8, IL-1b, IL-1a, TNF, and
PTGES in cDNA samples prepared above according to the
manufacturer’s instructions. After evaluation of several house-
keeping genes according to the MIQE-guidelines [40], glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) was chosen as the
most stable one with low variation between samples in the
microarray analysis. qPCR was carried out in 48-well optical
plates (Applied Biosystems, Life Technologies Corporation,
Warrington, UK) and each sample was measured in triplicate.
Measurements were made using a StepOne qPCR machine
(Applied Biosystems, Life Technologies Corporation, Warrington,
UK) and StepOne software version 2.1 (Applied Biosystems, Life
Technologies Corporation, Warrington, UK). PCR thermal
cycling conditions for each amplicon comprised of one cycle at
95uC for 10 mins, followed by 40 cycles at 95uC for 15 seconds
and 60uC for 60 seconds.
Changes in gene expression revealed by qPCR were calculated
by the 2DDCt method [41]. Normalization was carried out by
dividing their relative expression level by the relative expression
level of GAPDH.
Results
Confirmation of PCV2b infection in all cell types over
time
Quantitative PCR revealed the presence of increasing copy-
numbers of PCV2b in all three cell-types, with the highest copy
number being detected in alveolar macrophages (Fig. 1a). In
addition, specifically AMØs showed substantial cell-morphological
changes between 24 h mock-infected (Fig. 1b) and 24 h after
infection (Fig. 1d), as well as between 1 h after infection (Fig. 1c)
and 24 h after infection (Fig. 1d), as seen by light-microscopy,
compared to MoDC infected for the same length of time (Fig. 1 e–
f).
PCV2b challenge induces differential gene expression in
all three immune cell subsets, with monocyte-derived
dendritic cells showing highest differences
Differences in cell-specific gene expression of PCV2b chal-
lenged and unchallenged immune cell subsets derived from
individual animals (MoDCs, AMØs and BMCs) were assessed
using the Agilent Porcine Gene Expression Microarray with a cut-
off p-value of p,0.05 and a fold range of 21.5#FC$1.5.
Interestingly, some genes were differentially regulated at
timepoint 0. We hypothesise at the moment that this is not due
to the PCV2 infection, rather than handling of cells (adding virus,
washing of cells).
Overall, 92 genes showed differential expression, with the
number of differentially expressed genes increasing as infection
progresses (Fig. 2). As indicated above, all three immune cell
subsets were responsive to PCV2b infection and showed differen-
tial gene expression at an early (1 h) and late (24 h) time-point.
Interestingly however, substantial differences were seen between
the response of the different cell subsets to PCV2b exposure,
resulting in a minimal overlap of differentially-expressed tran-
scripts between MoDCs, AMØs and BMCs (Fig. 3). Among the
immune cell subset studied, and compared to mock-infection using
the cell culture supernatant of PK15 cells as control, MoDCs
showed the most marked response to PCV2b challenge with 40
and 30 transcripts differentially-regulated at 1 h and 24 h,
respectively (Fig. 2), whereas AMØs hardly reacted to the infection
at all, and BMCs showed the greatest number of down-regulated
genes (Fig. 2).
Independent of the cell-type, down-regulation of transcripts
appeared only 24 h post PCV2b-challenge, at a time-point when
PCV2b replication seemed to drop (see Fig. 1). At the early time
point (1 h p.i.), the profiles of gene expression in un-challenged
and PCV2b-challenged AMØs and BMCs were very similar, with
only one transcript (TNF) was significantly altered in AMØs
(Tab. 1). PCV2b challenge, however, had a clear early effect on
MoDCs, which showed 40 differentially regulated transcripts
(Tab. 1, Fig. 3, Tab. S1, Tab. S2), all of which were upregulated.
These transcripts included a plethora of genes involved in
inflammation and inflammatory responses, including NF-kB-
inducible chemokine and cytokine genes such as the (C-C motif)
ligand 20 gene (CCL20), interleukin 1 alpha and beta genes (IL-1a
and IL-1b), chemokine (C-X-C motif) ligand 2 (CXCL2), other
molecules involved in immune cell trafficking (ADM, CCL4,
MAP3K8, NFKBIA, OSM, STAB1, TIMP1 and TNF), antiviral
response genes (IRF1), and apoptosis-related genes (HBEGF, IRF1
(includes EG:16362), IER3, JAG1 and TNFAIP3).
At the late time-point, comparison of PCV2b-challenged
immune cell subsets and non-challenged control cells revealed a
total of 49 differentially expressed genes. Among the 30 genes
identified in MoDCs, 19 showed upregulation whereas 11 genes
Table 1. Cont.
Cell type Time-point p.i. Gene symbol FC Gene description
BMCs 0 h PLDN 1.56 pallidin homolog
BMCs 24 h Es25 3.9 Esterase 25
IGSF8 2.78 immunoglobulin superfamily, member 8
PTGES 2.54 prostaglandin E synthase
TMEM237 21.6 transmembrane protein 237
MMRN2 21.72 multimerin 2
MYL1 22.27 myosin, light chain 1
PEG10 22.57 paternally expressed 10
A total of 93 transcripts showed differential expression. Annotated transcripts are listed in each immune cell subset from the highest to the lowest fold-change at the
different time points p.i.
doi:10.1371/journal.pone.0091081.t001
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were down-regulated (Tab. 1, Fig. 2, Tab. S2). The main
transcripts with increased expression in MoDCs were VDAC1P5
(also known as VDAC5P or VDAC3, a voltage-dependent anion-
selective channel protein) the myeloid-related protein S100A9
(potent chemotactic factor for immune cells) and COX3 (involved
in prostaglandin biosynthesis). Other upregulated transcripts
included genes with apoptotic function (CASP10, RANBP1, VDAC2
and SLC25A6). Down-regulated transcripts with a FC#21.5
included ITGB5, PIK3IP1, SEPP2, RNASE4, DKK3 and DUOXA2.
Only seven genes were significantly upregulated in BMCs,
whereas 12 transcripts were down-regulated. Two of the top-
Table 2. Validation of microarray data by qRT-PCR.
Gene
name
TaqManH Gene
Expression Assay Microarray FC qRT qPCR FC
CXCL2 Ss03378360_u1 4.66 10.22
IL-8 Ss03392437_m1 4.40 17.58
IL-1b Ss03393804_m1 6.47 191.21
IL-1a Ss03391335_m1 3.20 18.09
TNF Ss03391318_g1 4.17 8.32
PTGNES Ss03392129_m1 2.54 11.92
doi:10.1371/journal.pone.0091081.t002
Figure 4. Biological process analysis of genes differentially expressed in MoDCs at 1 h and 24 h post PCV2b challenge. Differentially
expressed genes (P,0.05) were imported into IPA Ingenuity software to determine significantly enriched biological processes. Data represent the
distribution in cell function categories of statistically significantly enriched biological processes (P,0.05) at 0 h and 24 h post PCV2b challenge.
doi:10.1371/journal.pone.0091081.g004
Table 3. Downstream effect analysis of upregulated genes
involved in cell migration and infiltration in MoDCs 1 h post
PCV2b challenge.
ID FC Effect of Gene on Granulocyte/Leucocyte Infiltration
IL1B 6.470 Increase
CXCL2 4.660 Increase
IL8 4.400 Increase
TNF 4.170 Increase
CCL4 3.370 Increase
ADM 3.270 Decrease
IL1A 3.200 Increase
TNFAIP3 2.140 Decrease
NFKBIA 2.080 Increase
OSM 1.860 Increase
TIMP1 1.770 Decrease
doi:10.1371/journal.pone.0091081.t003
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ranking genes (ID BW961486 and 13183) could not be annotated,
however, IGSF8, a member of the immunoglobulin protein
superfamily functioning in cell migration and viral infection, and
PTGES, an inflammatory mediator, showed upregulation in BMCs
24 h after PCV2b-challenge (Tab. 1, Tab. S3). Four of the 12
transcripts downregulated in PCV2b-challenged BMCs were
annotated and included the transmembrane protein 237
(TMEM237), MMRN2, MYL1 and PEG10, a paternally-expressed
negative regulator of TGFb receptor signalling (Tab. 1, Tab. S3).
To corroborate these findings, quantitative real-time PCR
analysis was performed for several key pro-inflammatory media-
tors, these included CXCL2, IL-8, IL-1b, IL-1a, TNF and PTGNES
(Tab. 2). In general, the direction of upregulation correlated well
between the two platforms; however, the magnitude of fold change
was generally higher in the quantitative PCR approach.
PCV2b infection in MoDC promotes upregulation of
genes with granulocyte infiltration and apoptotic
function
Ingenuity Systems Pathway Analysis (IPA) allowed the identi-
fication of canonical pathways and functional processes affected by
PCV2b challenge. Pathways that were differentially affected
between PCV2-b challenged and non-challenged MoDCS at
1 h p.i. primarily involved the inflammatory responses and related
functional groups including NF-kB Signalling (1st ranked; P= 3.61E-
09) with seven out of the 175 genes present in this pathway
significantly affected, Role of proinflammatory hypercytokinemia/hyperch-
emokinemia (associated with Influenza pathology; Suppl. Fig. 1),
Innate and Adaptive Immune Cell Communication (3rd ranked), PPAR-,
IL-6- (4th, 5th respectively) and Communication between Innate and
Adaptive Immune Cells (P=2.25E-07) (Tabl. S1, Tab. S4).
Significant upregulation of five genes within proinflammatory
hypercytokinemia/hyperchemokinemia pathway (Fig. S1) indicated a
strong pro-inflammatory response associated with PCV2b chal-
lenge in MoDCs leading to the recruitment of immune cells to the
site of infection. As unique histopathological characteristic of
PMWS-affected pigs is excessive granulomatous inflammation in
the lymphoid tissues, genes with granulocyte/leukocyte infiltration
function were depicted separately in Tab. 3. All but three of the
genes (ADM, TNFAIP3 and TIMP1) showed a predicted increasing
effect facilitating granulocyte/leukocyte infiltration. Indeed, func-
tional analysis of differentially-expressed transcripts revealed an
enrichment of genes associated with immune cell trafficking,
inflammatory responses and immunological disease (Fig. 4, Tab.
S1).
Even with the large number of genes differentially expressed,
only 3 canonical pathways reached significance of p,0.05 at
24 h p.i., including Role of IL-17A in Psoriasis (p = 0.0136), RAN
Signalling (p = 0.0178) and Role of RIG1-like Receptors in Antiviral Innate
Immunity (p = 0.0454; Tab. S1, Tab. S3), an important pathway
involved in the host recognition of viral PAMPs. Interestingly,
none of the top ranking canonical pathways identified by IPA were
similar to those identified at the 1 h time-point.
Functional analysis revealed an enrichment of genes involved in
Cell Death, with largely increasing effects at both time-points (Fig. 4,
Tab. 4). PCV2-induced apoptosis may contribute to limiting the
host response [42], this may be particularly important during the
acute phase of infection when viral replication takes place [43]. An
enrichment of differentially expressed genes with functions in
apoptosis, both pro- and anti-apoptotic, were identified in MoDC
at both time-points with a shift towards a more pro-apoptotic state
at the later time-point where six out of nine genes have a predicted
increasing effect (Tab. 4). Further network analyses depicting the
top-networks of interacting genes for MoDC 1 h and 24 h after
PCV2b infection are shown in figures S3 and S4.
Functional pathway analysis reveals significant activation
of cellular development pathways in PCV2b infected
BMCs
While no differential gene expression was detected at one hour
post infection, 18 genes showed differential expression at 24 h with
seven genes significantly upregulated.
To gain a further insight into the potential mechanisms of the
effects of PCV2b challenge on BMCs, the identified transcripts
were mapped to networks available in the Ingenuity database.
Three networks were identified by scores between three and 13.
The scores take the number of focus molecules and the size of the
network into account to estimate the relevance of this network. In
accordance with the enrichment of genes with tissue development
Table 4. Downstream effect analysis of differentially-
expressed genes involved in apoptosis in MoDCs 1 h and 24 h
post PCV2b challenge.
Cell Type ID FC
Predicted Effect of
Gene on Apoptosis
MoDCs 1 h p.i.
IL1B 6.470 Increased
IL8 4.400 Increased
TNF 4.170 Increased
IER3 3.400 Increased
IL1A 3.200 Increased
MAP3K8 2.910 Increased
IRF1 2.100 Increased
NFKBIA 2.080 Increased
OSM 1.860 Increased
HBEGF 1.840 Affected
CXCL2 4.660 Decreased
CCL4 3.370 Decreased
ADM 3.270 Decreased
BTG2 2.350 Decreased
RND3 2.290 Decreased
JAG1 2.150 Decreased
TNFAIP3 2.140 Decreased
TIMP1 1.770 Decreased
INSR 1.600 Decreased
MoDCs 24 h p.i.
S100A9 3.3 Increase
SLC25A6 2.71 Increase
RTN4 2.25 Increase
CASP10 1.78 Increase
RANBP1 1.77 Affects
VDAC2 1.66 Increase
BTC 21.77 Increase
ITGB5 22.03 Decrease
PIK3IP1 22.05 Decrease
DKK3 22.29 Decrease
doi:10.1371/journal.pone.0091081.t004
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functions (Fig. 5), the highest-scoring network (Network Score 13)
revealed a significant link with connective tissue development and
function, embryonic and organ development (Fig. S2, Suppl.
Fig. 5, Tab. S3).
Among the top ranking canonical pathways identified by IPA,
several impact on immune response, including Eicosanoid Signalling
(1st ranked), important for its contribution to the inflammatory
response in a variety of diseases (such as arthritis and asthma) and
CXCR4 Signalling pathway (9th ranked) (Tab. S3). Prostaglandin E
Synthase (PTGES; FC= 2.54) was central to most pathways and
functions affected and has been shown to be induced by IL1- and
NFkB during inflammatory conditions [44]. Prostaglandin E
Synthase converts prostaglandin endoperoxide H2 (PGH2) to
prostaglandin E2 (PGE2), which is a potent immunoregulatory
lipid mediator with key roles in the regulation of virus replication
and modulation of inflammatory responses following infection
[45]. Indeed, PGE2 has not only been shown to downregulate IL-
12 and IL-23 production, two of the major driving cytokines for a
Th1 response [46], but also leads to the development of myeloid-
derived suppressor cells [47] and has dampening effects on MoDC
maturation [48].
Discussion
PCV-2 is the causative agent of PMWS, a widespread complex
multifactorial disease with recognized immunosuppressive charac-
teristics [18]. Compelling evidence suggests that the intricate
interaction between the host immune system to the presence of
PCV2 and the ability of PCV2 to interfere with immune defence is
a key event in the pathological outcome of PMWS. While
productive replication of PCV-2 is most likely restricted to
epithelial and endothelial cells [32,49], the virus has been shown
to infect and persist in cells of the immune system, including MØ,
DC and lymphocytes [14,50–52]. The current study assessed the
early molecular mechanisms involved in PCV2 infection of
immune cell subsets using a genome-wide expression approach.
To aid to the clinical significance of this study, a pathogenic
PCV2b strain currently circulating in the UK was used.
Similar as described in earlier publication [14,53], PCV2b
seems to readily infection of all three cell types in the absence of
clear viral replication. It is also interesting to mention that there
does not seem to be a correlation between viral copy numbers in
different cell-types and changes in gene expression levels as
analysed by microarray. Agilent microarray analysis of the
transcriptome differences between challenged and non-challenged
cells revealed a reduced host response of AMØs and BMCs to
PCV2b-challenge in vitro at both early and later time-points. This
result was particularly surprising considering AMØs are among
the first innate immune cell to encounter PCV2 in the lung [54]
and function in phagocytic clearance, inflammatory reactions and
tissue homeostasis [55], but may also be partially affected by the
experimental set-up in which cells were exposed to PCV2b at 0 h,
Figure 5. Biological process analysis of genes differentially expressed in BMCs at 1 h and 24 h post PCV2b challenge. Differentially
expressed genes (P,0.05) were imported into IPA Ingenuity software to determine significantly enriched biological processes. Data represent the
distribution in cell function categories of statistically significantly enriched biological processes (P,0.05) at 0 h and 24 h post PCV2b challenge.
doi:10.1371/journal.pone.0091081.g005
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and virus was washed off again straight away. However, this early
immunological ignorance of AMØs towards PCV2b infection has
been observed by others [53]. Indeed, a recent study utilising a
proteomics approach of AMØs infected with PCV2 revealed no
obvious changes at 24 h p.i., but resulted only in 9 up-regulated
and 12 down-regulated proteins at 48 h p.i. [56], which included
cytoskeleton proteins, macromolecular biosynthesis-associated
proteins, stress response proteins, signal transduction proteins,
energy metabolism, and ubiquitin proteasome pathway-associated
proteins. Moreover, nine corresponding genes of the differentially
expressed proteins were quantified by real time RT-PCR to
examine the transcriptional profiles. Thus, our data regarding
gene-expression differences in AMØs fit very well to these data
described by proteome-analysis. A decreased immune recognition
and response to PCV2b may be a genuine feature of these cells.
During the writing of this manuscript, results of a study were
published [57] showing that PCV2 infection of AMØs resulted in
differential regulation of far more genes than described here or in
Cheng et al [56]. Whereas the differences between these results are
not completely clear, they can potentially attributed to using a
different mock-infection (supernatant of PK15 cells here versus
media) or the MOI and virus strain used (UK strain versus
Chinese strain, MOI of 0.5 versus MOI of 1). Indeed, several
publications have shown that PCV2 isolates from China show a
rearranged genotype [58–62]. Further explanation for the
differences in results could be attributed to the treatment of cells
(frozen-thawed versus fresh in the current study) as well as the
testing for LPS (all reagents tested for LPS in the current study),
which may also explain the TLR activation described in the recent
publication [57]. Thus, whereas both studies identified the same
central molecules, the resulting differences may be attributed to
how the AMØs were treated rather than virus specific differences.
AMØs (24 h) and MoDCs (1 h) had increased gene expression
levels of TNF which also represented the only transcript common
to two of the three immune cells. TNF is produced by activated
MØs in response to microbial/viral stimuli and regulates a wide
range of biological activities, including cell differentiation,
proliferation and death, as well as inflammatory responses and
innate and adaptive immune responses [63–65]. An increase in
TNF expression in AMØs and MoDCs in response to viral triggers
agrees well with previous in vivo studies. Indeed, Kim et al. (2006)
[66] showed excessive production of TNFa´ by porcine parvovirus
(PPV) in a dual infection model in vivo, while PCV-2-challenge
alone did not induce TNFa´ to the same extent. Similar results
were obtained in a PRRSV/PCV-2 dual infection model of
AMØs in vitro [67,68]. Interestingly, in this model the excessive
production of TNF by the co-infecting pathogen potentiated PCV-
2-induced PMWS. Signalling through TNF activates various
downstream cascades, including activation of transcription factor
NF-kB and pro-apoptotic pro-caspases 8 and 10 [63]. In support
of this is the enrichment of genes in the NF-kB Signalling pathway
in MoDCs 1 h post PCV2b-challenge (Suppl. Tab. 1), the up-
regulation of caspase 10 and an enrichment of genes with mainly
pro-apoptotic functions 24 h post-challenge. Thereby, our findings
further demonstrate a clear role for TNF in the response to PCV-2
challenge in AMØs and MoDCs, substantiating a role of this key
cytokine in the aetiology of PMWS.
Further functional analysis of MoDCs revealed an enrichment of
genes involved in apoptosis with largely increasing effects at both
time-points (Tab. 4). The role of apoptosis in the development of
PMWS remains under investigation. While T- and B-lymphocyte
depletion in lymphoid tissues, lymphopenia in peripheral blood and
a reduction of B cells is a hallmark in pigs that progress to develop
clinical signs of PMWS [69], this decline may similarly result from
reduced proliferation rather than increased apoptosis [43]. How-
ever, it has been shown that ORF3 facilitates PCV-2-induced
apoptosis in vitro and in vivo [70]. This study has identified an
increased expression of more than 15 pro-apoptotic genes at both
time-points suggesting a potential role for apoptosis in the
pathogenesis of PMWS and characteristic lesions.
Significant upregulation of five genes within the ‘Proinflammatory
Hypercytokinemia/hyperchemokinemia’ pathway (Fig. S1) indicated a
strong pro-inflammatory response associated with PCV2b chal-
lenge in MoDCs, which resemble inflammatory DC in vivo [71],
leading to the recruitment of immune cells to the site of infection.
Indeed, a unique histopathological characteristic of PMWS-
affected pigs is excessive granulomatous inflammation in lymphoid
and other tissues [72]. Pathogenesis of these immune mediated
lesions includes the recruitment of circulating monocytes to the site
of inflammation [73]. This is facilitated by signalling through
NFkB, p38, or MAPKs-mediated regulation of pro-inflammatory
cytokine expression (IL1-b, TNF and IL-6) together with
chemokines and cell adhesion proteins [74]. This was further
supported by the enrichment of differentially-expressed transcripts
with biological functions in immune cell trafficking and cell-to-cell
signalling and the PCV2b-induced stimulation of pro-inflamma-
tory cytokines and chemoattractants as seen in MoDC are similar
to those seen in subclinically PCV2 infected pigs [25].
Antiviral immune responses in vivo are mediated by a variety of
cell types, thus, it is important to understand the dynamic
interaction between the immune cell subsets and viral pathogens,
including PCV2. Our present study has described the transcrip-
tional response of three immune cell subsets challenged with the
dominant UK PCV2b strain currently circulating on severely
PMWS-affected farms.
Analysis of the differentially-expressed genes showed a distinct
cell-type dependent response to PCV2b challenge and identified
several key molecules, functions and pathways involved in the host
response to PCV2b. The better understanding of these mecha-
nisms could provide new approaches to PCV2 infection and the
development of novel immunotherapies or vaccines for the
treatment of PMWS.
Supporting Information
Figure S1 Pathway ‘Role of Hypercytokinemia/hy-
perchemokinemia in the Pathogenesis of Influenza’.
Pathway analysis with the IPA software allowed identification of
pathways that were differentially expressed between PCV-2b-
challenged and unchallenged MoDCs 1 h post infection. The ‘Role
of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza’
pathway was one of the most affected pathways (P= 5.21E-09),
with five out of the 44 genes present significantly affected.
Significant upregulation of five genes within this pathway
indicated a strong pro-inflammatory response associated with
PCV-2b challenge in MoDCs.
(TIF)
Figure S2 Network Analysis of MoDC 1 h p.i. Analysis
with the IPA software identified transcripts that could be mapped
to networks available in the Ingenuity database. In MoDC
1 h p.i., four networks were identified with the highest ranking
network revealing a significant link with Cell-To-Cell Signaling
and Interaction, Cellular Growth and Proliferation, Renal and
Urological System Development and Function.
(TIF)
Figure S3 Network Analysis of MoDC 24 h p.i. Analysis
with the IPA software identified transcripts that could be mapped
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to networks available in the Ingenuity database. In MoDC
24 h p.i., only two networks were identified with the highest
ranking network revealing a significant link with Cell Death and
Survival, Cellular Development, Hematological System Develop-
ment and Function.
(TIF)
Figure S4 Network Analysis of BMCs 24 h p.i. Analysis
with the IPA software identified transcripts that could be mapped
to networks available in the Ingenuity database. In BMCs
24 h p.i., the highest ranking network revealed a significant link
with Cellular Development, Hematological System Development
and Function, Hematopoiesis.
(TIF)
Table S1 Pathway analysis of genes differentially
expressed in between PCV-2b-challenged and non-
challenged immune cell subsets. Differentially expressed
genes (P,0.05) were imported into the Ingenuity Pathways
Analysis (IPA) software. Canonical pathways analysis identified
the pathways from the IPA library of canonical pathways that were
most significant to the data set. Molecules from the data set that
met the 21.5# fold change $1.5 and a FDR-adjusted P,0.05
cutoff and were associated with a canonical pathway in the
Ingenuity Knowledge Base were considered for the analysis.
(DOCX)
Table S2 Gene list of DE genes grouped by IPA based on
gene function in MoDCs after 1 h and 24 h p.i. Genes in
red and bold represent significantly upregulated transcripts
expressed in this study. Genes in green and bold represent
significantly downregulated transcripts expressed in this study. A
network score of .2 was considered significant (p,0.01).
(DOCX)
Table S3 Gene list of DE genes grouped by IPA based on
gene function in BMCs after 24 h p.i. Genes in green and
bold represent significantly downregulated transcripts expressed in
this study. Genes in red and bold represent significantly
upregulated transcripts expressed in this study. A network score
of .2 was considered significant (p,0.01).
(DOCX)
Table S4 Pathway analysis of genes differentially
expressed in between PCV2b-challenged and non-chal-
lenged immune cell subsets. Differentially expressed genes
(P,0.05) were imported into the Ingenuity Pathways Analysis
(IPA) software. Canonical pathways analysis identified the
pathways from the IPA library of canonical pathways that were
most significant to the data set. Molecules from the data set that
met the 21.5# fold change $1.5 and a FDR-adjusted P,0.05
cutoff and were associated with a canonical pathway in the
Ingenuity Knowledge Base were considered for the analysis.
(DOCX)
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